Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000.

Authors:
Sun J; Su M; Ma J; Xu M; Ma C and 4 more

Journal:
Clin Epigenetics

Publication Year: 2023

DOI:
10.1186/s13148-023-01543-4

PMCID:
PMC10426093

PMID:
37582783

Journal Information

Full Title: Clin Epigenetics

Abbreviation: Clin Epigenetics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"availability of data and materials the supporting data and code are now available in github ( https://github com/sunjin1/mgiseq2000_novaseq6000_bs_com )."

Evidence found in paper:

"availability of data and materials the supporting data and code are now available in github ( https://github com/sunjin1/mgiseq2000_novaseq6000_bs_com )."

Evidence found in paper:

"Declarations Ethics approval and consent to participateThe clinical cfDNA samples and FFPE tissue were obtained from ProteoGenex (Inglewood, CA, USA). All clinical materials are obtained following official protocols, with appropriate Institutional Review Board/Independent Ethics Committee (IRB/IEC) approval. All subjects provided a written informed consent. Consent for publicationNot applicable. Competing interestsAll the authors are the employees of Singlera Genomics. Competing interests All the authors are the employees of Singlera Genomics."

Evidence found in paper:

"Funding This work was supported by National Key Research and Development Program of China (2019YFC1315800, 2019YFC1315801)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025